Financial Results



Financial Results Recent News

SNDL Reports Record CA$909M In Net Revenue For 2023, CEO Zach George Calls It 'Foundational' Period
Second-Largest Cannabis Retailer In North America Reports Record Revenue, Adjusted EBITDA In Q1
Cannabis Co. Cresco Nearly Doubles Adjusted EBITDA YoY To $54.8M In Q4, Narrows Loss In 2023
NY Cannabis Giant Cannabist's 2023 Revenue Consistent With Prior Year At $511M, Narrows Q4 Net Loss By 76% YoY
Cannabis REIT Chicago Atlantic's Net Income Grows 20% YoY In 2023
Cannabis REIT NewLake: YoY Increase In Q4 & FY 2023 Revenue Amid 'Challenging Environment,' CEO Says
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Nextleaf's Alberta Debut Results In 170% YoY Net Revenue Surge In Q1, Here's What's Next For The Cannabis Co.
Restructuring Plan Pays Off For Ancillary Cannabis Co. Despite YoY Net Sales Drop In Q4
Zig-Zag Segment Stable, Says CEO As Turning Point Reports Profit Increase And 6.1% YoY Drop In Q4 Net Sales
Canadian Cannabis Extractor Ayurcann's Q2 Revenue Jumps Over 81% YoY, Net Loss Grows
Planet 13 Cannabis Co. Shrinks Net Loss Over 60%, Achieves Positive EBITDA In Q4 Despite Industry Headwinds
Heritage Cannabis Co. Boosts Gross Margin Over 50% In 2023 Thanks To This Smart Move
Cannabis Co. Agrify Expects To Shrink Net Loss, Expand Gross Profit In Q4
Scotts Miracle-Gro's Cannabis-Focused Subsidiary Reports 39% YoY Revenue Drop In Q1
Cannabis Producer Nextleaf Reports 85% YoY Net Revenue Increase: '2023 Delivered Financial Stability'
Numinus Wellness Continues Tight Expense Management With Strategic Reviews Underway
Tilray's Diversified Growth Strategy Is Paying Off, Here's What's Behind 34% YoY Revenue Increase In Q2
Multi-Banner Cannabis Retailer's Q3 Revenue Slumps Over 42% YoY But CEO Remains Optimistic
CBD Giant's Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoY
Organic Growth And Innovation Drive YoY Increase In Cannabis Producer Organigram's Q4 Revenue And Adjusted EBITDA
Drive-Thru Cannabis Sales Help C21: Same-Store Sales Up, But Revenue Down In Q3
Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company?